Falcon Point Capital
PLXP

Falcon Point Capital’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Falcon Point Capital’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,854
Closed -$385K – 114
2016
Q2 		$385K Buy
4,854
+539
+12% +$46.7K 0.07% 92
2016
Q1 		$328K Buy
4,315
+2,118
+96% +$135K 0.06% 103
2015
Q4 		$197K Sell
2,197
-624
-22% -$59.9K 0.04% 113
2015
Q3 		$316K Buy
+2,821
New +$325K 0.11% 103

Other funds holding PLXP

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Tourbillon Capital Partners
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Great Point Partners
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lone Star Value Management
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
Lombard Odier Asset Management (USA)
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
Emerald Acquisition
Emerald Acquisition Seattle, Washington $51.8B AUM
Timpani Capital Management
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
Raymond James & Associates
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Falcon Point Capital's PLXP Position: Q3 2016 in Review

Falcon Point Capital sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2016, closing a stake of 4,854 shares — an estimated $385K sold.

Falcon Point Capital first reported a position in PLXP in Q3 2015 and held it in 4 quarters. The position peaked at $385K in Q2 2016. 32 funds tracked by Wall St. Rank hold PLXP as of Q3 2016.

  • Falcon Point Capital reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Falcon Point Capital sold 4,854 PLx Pharma Inc. Common Stock shares in Q3 2016, an estimated $385K.
  • Falcon Point Capital first reported a position in PLx Pharma Inc. Common Stock in Q3 2015 and held it in 4 quarters.
  • Falcon Point Capital's PLx Pharma Inc. Common Stock position peaked at $385K in Q2 2016.
  • 32 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2016.

Based on Falcon Point Capital's 13F filing for Q3 2016, filed 8 Nov 2016.